US Patent 11325981 Bispecific antigen-binding constructs targeting Her2
Patent 11325981 was granted and assigned to Zymeworks Inc. on May, 2022 by the United States Patent and Trademark Office.
Is a
Date Filed
June 18, 2018
0
Date of Patent
May 10, 2022
0
Patent Application Number
16011048
0
Patent Inventor Names
Eric Escobar-Cabrera
0
Surjit Bhimarao Dixit
0
Nina E. Weisser
0
Mario Sanches
0
Grant Raymond Wickman
0
Gordon Yiu Kon Ng
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11325981 Bispecific antigen-binding constructs targeting Her2
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
